[Guideline-conforming interventional treatment of acute ST-segment elevation myocardial infarction in rural areas

H Schneider1, F Weber, L Paranskaja

  • 1Drip and Ship Netzwerk der Universität Rostock.

Insights

Regional networks enable timely percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) patients in rural areas. This approach ensures rapid reperfusion, improving outcomes comparable to direct hospital admission.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Health Services Research

Context:

  • Acute myocardial infarction (STEMI) requires rapid reperfusion.
  • Primary percutaneous coronary intervention (PCI) is superior to thrombolytic therapy but often unavailable in rural settings.
  • Regional infarction networks can bridge this gap by connecting community hospitals to specialized centers.

Purpose:

  • To evaluate the efficacy and outcomes of a regional infarction network model for STEMI treatment in rural Germany.
  • To compare outcomes between STEMI patients transferred from community hospitals to a central interventional center versus those admitted directly.

Summary:

  • A 14-month study involved 322 STEMI patients treated via PCI within a regional network.
  • 160 patients were transferred from community hospitals, and 162 were admitted directly to the interventional center.
  • Key outcomes including infarct size, mortality, and ejection fraction were similar between the transfer and direct admission groups, demonstrating comparable efficacy.

Impact:

  • Regional infarction networks facilitate timely PCI for STEMI patients in underserved rural areas.
  • This model ensures adherence to treatment guidelines and achieves outcomes similar to direct PCI center admissions.
  • Successful implementation demonstrates the feasibility of improving acute myocardial infarction care through organized regional collaboration.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...